$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

$psbd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024040236 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$15.76M	$16.32M	$29.82M
YoY Change	10.97%	20.05%
Cost Of Revenue	$19.70M	$17.52M	$14.04M
YoY Change
Gross Profit	$16.85M	$17.27M	$15.78M
YoY Change
Gross Profit Margin	106.95%	105.8%	52.93%
Selling, General & Admin	$1.095M	$997.4K	$675.5K
YoY Change
% of Gross Profit	6.5%	5.78%	4.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$20.79M	$18.52M	$394.0K
YoY Change	54.04%	44.31%
Operating Profit	-$3.939M	-$1.252M	$15.39M
YoY Change	-70.25%	-90.06%
Interest Expense	-$10.45M	$13.18M	$6.563M
YoY Change		27.68%
% of Operating Profit			42.64%
Other Income/Expense, Net
YoY Change
Pretax Income	$5.313M	$22.88M	$21.95M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$5.313M	$22.88M	$21.95M
YoY Change	-77.81%	-18.54%
Net Earnings / Revenue	33.72%	140.21%	73.61%
Basic Earnings Per Share	$0.48	$0.52
Diluted Earnings Per Share	$0.48	$0.52	$0.67
COMMON SHARES
Basic Shares Outstanding	32.57M shares	31.59M shares	26.67M shares
Diluted Shares Outstanding	32.57M shares	31.59M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.79M	$8.255M	$2.117M
YoY Change
Cash & Equivalents	$14.79M	$8.255M	$2.117M
Short-Term Investments
Other Short-Term Assets	$167.1K	$85.52K	$30.10K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$15.91M	$9.318M	$4.609M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.432B	$1.393B	$1.109B
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.443B	$1.403B	$1.117B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$15.91M	$9.318M	$4.609M
Total Long-Term Assets	$1.443B	$1.403B	$1.117B
Total Assets	$1.459B	$1.413B	$1.122B
YoY Change	34.87%	33.23%	6.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$68.24M	$37.58M	$14.71M
YoY Change
Accrued Expenses	$1.314M	$944.4K	$1.068M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$89.56M	$58.82M	$18.03M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$820.4M	$795.2M	$641.8M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$820.4M	$795.2M	$641.8M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$89.56M	$58.82M	$18.03M
Total Long-Term Liabilities	$820.4M	$795.2M	$641.8M
Total Liabilities	$910.0M	$854.0M	$659.9M
YoY Change	38.9%	29.86%	-4.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.80M	-$51.81M	-$58.73M
YoY Change			-46.85%
Common Stock	$610.6M	$610.3M	$520.7M
YoY Change	2369005.82%	2443714.65%	2143805.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$548.8M	$558.5M	$462.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.459B	$1.413B	$1.122B
YoY Change	34.87%	33.23%	6.09%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$5.313M	$22.88M	$21.95M
YoY Change	-77.81%	-18.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$513.5K	-$237.9M	$3.407M
YoY Change		-951.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$89.65M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.047M	$244.0M	-4.700M
YoY Change		-1144.88%
NET CHANGE
Cash From Operating Activities	-513.5K	-$237.9M	3.407M
Cash From Investing Activities
Cash From Financing Activities	7.047M	$244.0M	-4.700M
Net Change In Cash	6.534M	$6.138M	-1.294M
YoY Change		33.69%
FREE CASH FLOW
Cash From Operating Activities	-$513.5K	-$237.9M	$3.407M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.14
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31594552	shares
CY2023Q1	cik0001794776	Increasedecrease In Directors Fee Payable IncreasedecreaseInDirectorsFeePayable		usd
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2023Q4	us-gaap	Distribution Payable DistributionPayable		usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.72
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24591581	shares
CY2024Q1	us-gaap	Distribution Payable DistributionPayable	15950869	usd
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	2416239	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	2252075	usd
CY2024Q1	us-gaap	Incentive Fee Payable IncentiveFeePayable	1924752	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	944394	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-56126
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Palmer Square Capital BDC Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3665200
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Shawnee Mission Parkway
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 315
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Mission Woods
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	66205
CY2024Q1	dei	City Area Code CityAreaCode	(816)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	994-3200
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	PSBD
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32570906	shares
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1435202874	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1159135422	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1393192087	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1108810753	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8255216	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2117109	usd
CY2024Q1	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	84257	usd
CY2023Q4	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	97141	usd
CY2024Q1	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	450778	usd
CY2023Q4	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	344509	usd
CY2024Q1	cik0001794776	Due From Investment Adviser DueFromInvestmentAdviser	84627	usd
CY2023Q4	cik0001794776	Due From Investment Adviser DueFromInvestmentAdviser	1718960	usd
CY2024Q1	us-gaap	Dividends Receivable DividendsReceivable	357253	usd
CY2023Q4	us-gaap	Dividends Receivable DividendsReceivable	301637	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	10032505	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	8394509	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	85517	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	30100	usd
CY2024Q1	us-gaap	Assets Assets	1412542240	usd
CY2023Q4	us-gaap	Assets Assets	1121814718	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	795184728	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	641828805	usd
CY2024Q1	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	37584094	usd
CY2023Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	14710524	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1067921	usd
CY2024Q1	us-gaap	Liabilities Liabilities	854005076	usd
CY2023Q4	us-gaap	Liabilities Liabilities	659859325	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32552794	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32552794	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27102794	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27102794	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	32553	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	27103	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	610310156	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	520663106	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51805545	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58734816	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	558537164	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461955393	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1412542240	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121814718	usd
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.16
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.04
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	33259959	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	25452738	usd
CY2024Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1254696	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	676868	usd
CY2024Q1	us-gaap	Other Income OtherIncome	270288	usd
CY2023Q1	us-gaap	Other Income OtherIncome	55896	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	34784943	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	26185502	usd
CY2024Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	34784943	usd
CY2023Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	26185502	usd
CY2024Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1924752	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	13178830	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	10322130	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	2416239	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1912228	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	237943	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	211994	usd
CY2024Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37295	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18493	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	722166	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	367006	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	18517225	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12831851	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	50511	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	239028	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18466714	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-12592823	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	16318229	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	13592679	usd
CY2024Q1	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-1736331	usd
CY2023Q1	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-317446	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1736331	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2024Q1	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-8298242	usd
CY2023Q1	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-14813089	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8298242	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	6561911	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	14495643	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	22880140	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	28088322	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.72
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31594552	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24591581	shares
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	16318229	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	13592679	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1736331	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8298242	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	22880140	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	28088322	usd
CY2024Q1	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-15950869	usd
CY2024Q1	cik0001794776	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-15950869	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	89652500	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11104225	usd
CY2024Q1	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	89652500	usd
CY2023Q1	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	11104225	usd
CY2024Q1	cik0001794776	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	96581771	usd
CY2023Q1	cik0001794776	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	39192547	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461955393	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	558537164	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	402636029	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	22880140	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	28088322	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1736331	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8298242	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	578578	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	352426	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	295848981	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	230510615	usd
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	346482823	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	63457688	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	295534623	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	181245181	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	69556336	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	102138907	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	289630	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	244963	usd
CY2024Q1	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-12884	usd
CY2023Q1	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-26972780	usd
CY2024Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	1693612	usd
CY2023Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-369626	usd
CY2024Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-1634333	usd
CY2023Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	4926	usd
CY2024Q1	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	106269	usd
CY2023Q1	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	106753	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55417	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5699	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1308707	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2377711	usd
CY2024Q1	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	22873570	usd
CY2023Q1	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-4583253	usd
CY2024Q1	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	164164	usd
CY2023Q1	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	39413	usd
CY2024Q1	cik0001794776	Increasedecrease In Directors Fee Payable IncreasedecreaseInDirectorsFeePayable	-1924752	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-123527	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-13943	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-237889393	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27945957	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	158000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27500000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3625000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	17726	usd
CY2023Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	6941066	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89652500	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11104225	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	244027500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23354567	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6138107	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4591390	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2117109	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650801	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8255216	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6242191	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	14487537	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7944419	usd
CY2024Q1	cik0001794776	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod	15950869	usd
CY2024Q1	cik0001794776	Distributions Payable DistributionsPayable	15950869	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Indemnifications</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</p>
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.90	pure
CY2024Q1	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
CY2024Q1	cik0001794776	Renewed Period RenewedPeriod	P2Y
CY2024Q1	cik0001794776	Weighted Average Number Of Shares Outstanding Percentage WeightedAverageNumberOfSharesOutstandingPercentage	0.0175	pure
CY2024Q1	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	0.02	pure
CY2024Q1	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.0175	pure
CY2024Q1	cik0001794776	Hurdle Rate Percentage In Each Quarter HurdleRatePercentageInEachQuarter	0.015	pure
CY2024Q1	cik0001794776	Hurdle Rate Percentage In Annual Term HurdleRatePercentageInAnnualTerm	0.06	pure
CY2024Q1	cik0001794776	Percentage Of Adjusted Net Investment Income PercentageOfAdjustedNetInvestmentIncome	1	pure
CY2024Q1	cik0001794776	Catch Up Amount Determining Percentage CatchUpAmountDeterminingPercentage	0.017142	pure
CY2024Q1	cik0001794776	Incentive Fee Percentage IncentiveFeePercentage	0.125	pure
CY2024Q1	cik0001794776	Incentive Fee Percentage Equals Adjusted Net Investment Income IncentiveFeePercentageEqualsAdjustedNetInvestmentIncome	0.125	pure
CY2024Q1	cik0001794776	Due From Advisor DueFromAdvisor	100000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1435202874	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1393192087	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1159135422	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1108810753	usd
CY2024Q1	cik0001794776	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.177	pure
CY2024Q1	cik0001794776	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.179	pure
CY2023	cik0001794776	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.142	pure
CY2023	cik0001794776	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.141	pure
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.168	pure
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.132	pure
CY2024Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2024Q1	us-gaap	Investments Investments	1393192087	usd
CY2023Q4	us-gaap	Investments Investments	1108810753	usd
CY2024Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	1.50	pure
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5450000	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5450000	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	89700000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	15000000	usd
CY2024Q1	cik0001794776	Aggregate Purchase Prices AggregatePurchasePrices	5000000	usd
CY2024Q1	cik0001794776	Aggregate Unfunded Commitments AggregateUnfundedCommitments	30800000	usd
CY2023Q4	cik0001794776	Aggregate Unfunded Commitments AggregateUnfundedCommitments	20100000	usd
CY2024Q1	cik0001794776	Unfunded Commitments UnfundedCommitments	30793817	usd
CY2023Q4	cik0001794776	Unfunded Commitments UnfundedCommitments	20107358	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.04
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
CY2024Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.52
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.55
CY2024Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.09
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.61
CY2024Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.61
CY2023Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.16
CY2024Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.49
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.16
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.12
CY2024Q1	us-gaap	Shares Outstanding SharesOutstanding	32552794	shares
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	24975302	shares
CY2024Q1	us-gaap	Assets Net AssetsNet	558537164	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	402636029	usd
CY2024Q1	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	31594552	shares
CY2023Q1	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	24591581	shares
CY2024Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.037	pure
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0775	pure
CY2024Q1	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.06	pure
CY2023Q1	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.07	pure
CY2024Q1	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.137	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.1342	pure
CY2024Q1	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1366	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1317	pure
CY2024Q1	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1203	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1397	pure
CY2024Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1207	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1422	pure
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.49
CY2024Q1	us-gaap	Distribution Payable DistributionPayable	15950869	usd
CY2024Q1	cik0001794776	Percentage Of Subordinated Notes PercentageOfSubordinatedNotes	1	pure
CY2024Q1	us-gaap	Subordinated Debt SubordinatedDebt	100500000	usd
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2023Q1	cik0001794776	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders		usd
CY2023Q1	cik0001794776	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains		usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2024Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates		usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2023Q1	cik0001794776	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod		usd
CY2023Q1	cik0001794776	Distributions Payable DistributionsPayable		usd
CY2024Q1	cik0001794776	Additional Renewed Period AdditionalRenewedPeriod	P1Y
CY2023Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001794776

Files In Submission

Name	View Source	Status
0001213900-24-040236-index-headers.html	Edgar Link	pending
0001213900-24-040236-index.html	Edgar Link	pending
0001213900-24-040236.txt	Edgar Link	pending
0001213900-24-040236-xbrl.zip	Edgar Link	pending
cik0001794776-20240331.xsd	Edgar Link	pending
ea0204328-10q_palmer.htm	Edgar Link	pending
ea020432801ex31-1_palmer.htm	Edgar Link	pending
ea020432801ex31-2_palmer.htm	Edgar Link	pending
ea020432801ex32-1_palmer.htm	Edgar Link	pending
ea020432801ex32-2_palmer.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
cik0001794776-20240331_cal.xml	Edgar Link	unprocessable
cik0001794776-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0204328-10q_palmer_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cik0001794776-20240331_pre.xml	Edgar Link	unprocessable
cik0001794776-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

2024 Q2 Form 10-Q Financial Statement

#000121390024040236 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD Palmer Square Capital BDC Inc. Stock $psbd

2024 Q2 Form 10-Q Financial Statement

#000121390024040236 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd